International journal of dermatology
Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3.
Ernest H Law, Bintu Sherif, Arash Mostaghimi, Brett King, Rodney Sinclair, Natasha Mesinkovska, Kent A Hanson, Dane Korver, Costel Chirila
Published: 202510.1111/ijd.70035
Abstract
BACKGROUND: Patients with alopecia areata (AA) in ALLEGRO-2b/3 (NCT03732807) had clinically significant hair regrowth and patient-reported improvements with ritlecitinib versus placebo, but patient-reported improvements in AA Patient Priority Outcome…
Preview only. Read the full abstract at the source